Current Status of Neoadjuvant Therapy for Adenocarcinoma of the Distal Esophagus

[1]  T. Walsh,et al.  Neoadjuvant treatment of advanced stage esophageal adenocarcinoma increases survival. , 2002, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[2]  M. Schwaiger,et al.  Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  M. Schwaiger,et al.  Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma: Response Evaluation by Positron Emission Tomography , 2001, Annals of surgery.

[4]  M. Iannettoni,et al.  Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  D. Kelsen.  Preoperative chemoradiotherapy for esophageal cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. Siewert,et al.  Neue Therapieansätze bei Tumoren des oberen Gastrointestinaltrakts (Oesophagus, Magen) , 2000, Der Chirurg.

[7]  M. Ducreux,et al.  A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma. , 2000, European journal of cancer.

[8]  C. Willett,et al.  Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  M. Suntharalingam,et al.  P53 gene protein overexpression predicts results of trimodality therapy in esophageal cancer patients. , 1999, The Annals of thoracic surgery.

[10]  J. Siewert,et al.  Surgical resection for cancer of the cardia. , 1999, Seminars in surgical oncology.

[11]  K. Cheng,et al.  Classification of adenocarcinoma of the oesophagogastric junction , 1999, The British journal of surgery.

[12]  G. ZuccaroJr..  Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer , 1999 .

[13]  S. Medendorp,et al.  Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer , 1999, American Journal of Gastroenterology.

[14]  J. Goldblum,et al.  Overexpression of p53 protein associates decreased response to chemoradiotherapy in patients with esophageal carcinoma. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[15]  J. Ajani,et al.  Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. , 1998, The New England journal of medicine.

[16]  W. Yin,et al.  Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)--report on 370 patients. , 1998, International journal of radiation oncology, biology, physics.

[17]  L. Weiner,et al.  High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction , 1998, Cancer.

[18]  R. Day,et al.  Efficacy of cisplatin, 5-fluorouracil, and paclitaxel regimen for carcinoma of the esophagus. , 1997, Seminars in oncology.

[19]  S. Urba.  Combined-modality treatment of esophageal cancer. , 1997, Oncology.

[20]  D. Kelsen.  Multimodality therapy for adenocarcinoma of the esophagus. , 1997, Gastroenterology clinics of North America.

[21]  J. Menten,et al.  Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[22]  S. Taylor,et al.  Integration of surgery in multimodality therapy for esophageal cancer. , 1997, American journal of clinical oncology.

[23]  T. Walsh,et al.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. , 1996, The New England journal of medicine.

[24]  H. Wilke,et al.  Multimodal therapy for adenocarcinoma of the esophagus and esophagogastric junction. , 1996, The New England journal of medicine.

[25]  A. Norman,et al.  Epirubicin, cisplatin, and protracted venous infusion of 5‐fluorouracil for esophagogastric adenocarcinoma: Response, toxicity, quality of life, and survival , 1996, Cancer.

[26]  M. Sivak,et al.  Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation. , 1996, Gastrointestinal endoscopy.

[27]  H. Höfler,et al.  Prognostic factors of resected adenocarcinoma of the esophagus. , 1995, Surgery.

[28]  N. Mulder,et al.  Neo-adjuvant chemotherapy with carboplatin, 4-epiadriamycin and teniposide (CET) in locally advanced cancer of the cardia and the lower oesophagus: a phase II study. , 1995, Anticancer research.

[29]  N. Choi,et al.  Evolution of treatment strategies for adenocarcinoma of the esophagus and gastroesophageal junction. , 1994, The Annals of thoracic surgery.

[30]  H. Dittler,et al.  Response to Chemotherapy in Esophageal Cancer , 1994, Endoscopy.

[31]  P. Freeny.  Adenocarcinoma of the esophagus and gastroesophageal junction. , 1994, Seminars in roentgenology.

[32]  M. Sivak,et al.  Adenocarcinoma of the Esophagus and Gastroesophageal Junction Clinical and Pathologic Assessment of Response to Induction Chemotherapy , 1994, American journal of clinical oncology.

[33]  S. Hoff,et al.  Improved Survival with Neoadjuvant Therapy and Resection for Adenocarcinoma of the Esophagus , 1993, Annals of surgery.

[34]  M. Orringer,et al.  Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  T. Roy,et al.  Preoperative chemotherapy and radiotherapy for esophageal carcinoma. , 1992, The Journal of thoracic and cardiovascular surgery.

[36]  M. Orringer,et al.  Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma , 1992, Cancer.

[37]  N. Choi,et al.  A pilot study of neoadjuvant chemotherapy with 5‐fluorouracil and cisplatin with surgical resection and postoperative radiation therapy and/or chemotherapy in adenocarcinoma of the esophagus , 1991, Cancer.

[38]  Stephen E. Jones,et al.  Adjuvant Therapy of Cancer , 1990 .

[39]  J. Ajani,et al.  Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  M. Rotman,et al.  Concomitant continuous infusion chemotherapy and radiation , 1990, Medical Radiology.

[41]  S. Steinberg,et al.  Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. , 1988, The Journal of thoracic and cardiovascular surgery.

[42]  J. Siewert,et al.  [New therapy approaches in tumors of the upper gastrointestinal tract (esophagus, stomach)]. , 2000, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[43]  G. Monges,et al.  Prognostic value of p53 protein expression in squamous cell carcinoma of the esophagus. , 1996, Cancer detection and prevention.

[44]  F. Detterbeck,et al.  Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  J. Ajani,et al.  Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction. , 1995, European journal of cancer.

[46]  J. Siewert,et al.  Esophageal Cancer: Neoadjuvant therapy for squamous cell esophageal carcinoma , 1994 .

[47]  J. Ajani,et al.  Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  J. Crawford,et al.  Adenocarcinoma of the Gastroesophageal Junction: Preoperative Cisplatin and Concomitant Continuous Infusion 5-Fluorouracil and Radiation Therapy , 1991 .